BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2773587)

  • 1. [Effectiveness of the new Soviet immunomodulator mielopid in the combined treatment of patients with chronic pyoderma].
    Petrova IV; Leshchenko GM; Bystritskaia TF
    Vestn Dermatol Venerol; 1989; (5):67-9. PubMed ID: 2773587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new approach to the therapy of pyoderma in servicemen: the use of the actoprotector bemitil].
    Samtsov AV; Tarasenko GN; Smirnov AV
    Voen Med Zh; 1998 May; 319(5):50-4, 96. PubMed ID: 9680838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunocorrective therapy of pyoderma caused by staphylococci multiply resistant to antibiotics].
    Rodionov AN; Khavinson VKh; Barbinov VV
    Vestn Dermatol Venerol; 1990; (1):42-5. PubMed ID: 2327170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The combined therapy of chronic pyoderma taking into account body immunological reactivity and staphylococcal antibiotic resistance].
    Rodionov AN; Khavinson VKh; Barbinov VV
    Voen Med Zh; 1992 Aug; (8):28-30. PubMed ID: 1441267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunity in patients with ulcerous forms of chronic pyoderma undergoing treatment].
    Mazina NM; Baltabaev MK
    Vestn Dermatol Venerol; 1989; (3):48-51. PubMed ID: 2741546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic nonspecific lung diseases, immunological deficiency and the means of its correction].
    Chuchalin AG; Arion VIa; Babushkina VA; Krotova SB; Portnova AP
    Ter Arkh; 1984; 56(10):10-4. PubMed ID: 6335304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in chronic pyoderma.
    Papageorgiou P; Kesarwala HH; Alcid DV; Szep R; Kulkarni KN; Gocke DJ
    J Clin Lab Immunol; 1982 Jun; 8(2):121-7. PubMed ID: 7108939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunocorrecting therapy in focal scleroderma].
    Suchkova TN; Prozorovskaia NN; Suchkov SV; Del'vig AA
    Vestn Dermatol Venerol; 1987; (9):8-14. PubMed ID: 3424992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Information value of immunological follow-up tests in the thymalin treatment of pyodermatitis patients].
    Pastushenkov VL; Grishanin VA; Mazing IuA
    Voen Med Zh; 1987 Aug; (8):28-30. PubMed ID: 3672984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of lincomycin in pyoderma].
    Fedorovskaia RF; Zimina LP; Khapilova VI; Danilova TN
    Vestn Dermatol Venerol; 1976 Jun; (6):55-9. PubMed ID: 1014841
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined method of relapse-preventing treatment of chronic pyoderma patients].
    Topuriia RS
    Vestn Dermatol Venerol; 1984 Mar; (3):56-9. PubMed ID: 6730670
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and electron microscopy evaluation of therapeutic effectiveness in chronic pyoderma using antibiotics in combination with dekaris (levamisole)].
    Kalamkarian AA; Delektorskiĭ VV; Padarian GN; Voskresenskaia GA
    Vestn Dermatol Venerol; 1982 Jun; (6):4-10. PubMed ID: 7124107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the Gepon immunomodulator for ulcerative colitis treatment].
    Malakhova NS; Pichugin AV; Khalif IL; Ataullakhanov RI
    Eksp Klin Gastroenterol; 2005; (1):14-9, 106. PubMed ID: 15991847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 18. [Levamisole treatment of pyoderma].
    Zaĭtseva SIu; Mashkilleĭson AL; Lebedev KA
    Vestn Dermatol Venerol; 1981; (10):45-8. PubMed ID: 6458170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of immunotropic preparations in chronic bronchitis].
    Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu; Semin SN; Ogarkov VI
    Ter Arkh; 1988; 60(3):42-5. PubMed ID: 2968678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.